Front Barnett Associates’s BIOJECT MEDICAL TECHS INC BJCT Stock Holding History

Front Barnett Associates’s Portfolio BJCT Stock Details BJCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-87,500	Closed	–	–	124
2016 Q4	$0	Hold	87,500	–	–	﹤0.01%	125
2016 Q3	$0	Hold	87,500	–	–	﹤0.01%	122
2016 Q2	$0	Hold	87,500	–	–	﹤0.01%	123
2016 Q1	$0	Hold	87,500	–	–	﹤0.01%	121
2015 Q4	$5K	Hold	87,500	–	–	﹤0.01%	119
2015 Q3	$5K	Hold	87,500	–	–	﹤0.01%	114
2015 Q2	$4K	Hold	87,500	–	–	﹤0.01%	117
2015 Q1	$8K	Hold	87,500	–	–	﹤0.01%	120
2014 Q4	$9K	Hold	87,500	–	–	﹤0.01%	116
2014 Q3	$19K	Hold	87,500	–	–	﹤0.01%	116
2014 Q2	$17K	Hold	87,500	–	–	﹤0.01%	113
2014 Q1	$14K	Hold	87,500	–	–	﹤0.01%	109
2013 Q4	$7K	Hold	87,500	–	–	﹤0.01%	109
2013 Q3	$6K	Hold	87,500	–	–	﹤0.01%	111
2013 Q2	$10K	Buy	+87,500	New	+$10K	﹤0.01%	108

Front Barnett Associates's BJCT Position: Q1 2017 in Review

Front Barnett Associates sold out of BIOJECT MEDICAL TECHS INC (BJCT) in Q1 2017, closing a stake of 87,500 shares.

Front Barnett Associates first reported a position in BJCT in Q2 2013 and held it in 15 quarters. The position peaked at $19K in Q3 2014. 0 funds tracked by Wall St. Rank hold BJCT as of Q1 2017.

Front Barnett Associates reported no remaining BIOJECT MEDICAL TECHS INC position as of Q1 2017 after selling out during the quarter.
Front Barnett Associates sold 87,500 BIOJECT MEDICAL TECHS INC shares in Q1 2017.
Front Barnett Associates first reported a position in BIOJECT MEDICAL TECHS INC in Q2 2013 and held it in 15 quarters.
Front Barnett Associates's BIOJECT MEDICAL TECHS INC position peaked at $19K in Q3 2014.
0 funds tracked by Wall St. Rank held BIOJECT MEDICAL TECHS INC as of Q1 2017.

Based on Front Barnett Associates's 13F filing for Q1 2017, filed 2 May 2017.